ARIMIDEX is indicated for that treatment of State-of-the-art breast most cancers in postmenopausal Females with illness development following tamoxifen therapy. Patients with ER-damaging sickness and patients who did not respond to past tamoxifen therapy hardly ever responded to ARIMIDEX. The overall quantity of deaths (during or off-trial procedure) was similar https://lewisu987hyn5.wikibyby.com/user